Axio BioPharma sell "Recombinant Protein Manufacturing Services"

Axio BioPharma is a trusted innovator supplying high-quality recombinant proteins to meet biopharma industry demands, aiming to be a preferred partner in advancing customers' biologics programs. The company focuses on research-grade manufacturing of monoclonal antibodies (mAbs), specializing in small-scale production from 10 mL to 20 L. Its team of industry-leading experts is equipped to address each program's unique challenges, delivering efficient and reliable results. Axio BioPharma supports mammalian-expressed proteins and offers scalable production, giving flexibility to meet evolving R&D program needs.